Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients
Status:
Active, not recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
Sinonasal tumors are rare diseases, so no standard treatment for such aggressive tumors has
been reported, given rarity, absence of prospective study and heterogeneity of histologies
and stages of diseases. This study proposes innovative integration of multiple modality of
treatment depending by histology, molecular profile and response to induction CT. Moreover,
such strategies allows the use of latest technology with greater biological effectiveness and
reduction of toxicities.
Phase:
Phase 2
Details
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano